Dark

RGC
Regencell Bioscience Holdings Limited
stock NASDAQ

At Close

Sep 3, 2025 3:59:30 PM EDT

13.78USD+7.198%(+0.93)311,086

0.00Bid 0.00Ask 0.00Spread

Pre-market

Sep 3, 2025 9:16:30 AM EDT

13.03USD+1.401%(+0.18)3,128

After-hours

Sep 3, 2025 4:44:30 PM EDT

13.83USD+0.399%(+0.06)31,996

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

6.82B

Headquarters

TN, USA

Industry

Drug Manufacturers-Specialty & Generic

Next Earnings

Oct 24, 2025 (50d)

Last Split

Jun 16, 202538for1

RDI MCS CNK AMC

RGC Stats

Avg. Vol. 10 Day

330,174

Avg. Vol. 30 Day

403,817

Employees

26,000

Market Cap

6,821,474,486

Shares Out.

494,488,908

On/Off Exchange

57%/43%

6 Month Beta

-0.66

1 Year Beta

-0.40

2 Year Beta

-0.14

3 Year Beta

-0.07

52 Week Low

0.09

52 Week High

83.60

SMA50

15.01

SMA200

7.03

1 Week

-3.13%

1 Month

+0.25%

3 Month

-13.94%

6 Month

+12,840.90%

1 Year

+7,901.74%

2 Year

+3,420.93%

5 Year

+4,892.76%

Profile

we are an early-stage bioscience company that focuses on research, development and commercialization of tcm for the treatment of neurocognitive disorders and degeneration, specifically attention deficit hyperactivity disorder ("adhd"), autism spectrum disorder ("asd") in infectious diseases such as covid-19. our goal is to improve the lives of adhd, asd and covid patients, their families and caregivers and become a market leader for the best tcm treatment globally.

RGC Stock Summary

Regencell Bioscience Holdings Limited (NASDAQ:RGC) stock price today is $13.78, and today's volume is 311,086. RGC is up 7.198% today. The 30 day average volume is 403,817. RGC market cap is 6.82B with 494,488,908 shares outstanding.